Antral follicle count and anti-Müllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
El Tokhy O, Kopeika J, El-Toukhy T: An update on the prevention of ovarian hyperstimulation syndrome. Womens Health (Lond) 2016; 12: 496–503.El TokhyOKopeikaJEl-ToukhyT:An update on the prevention of ovarian hyperstimulation syndrome.Womens Health (Lond)2016;12:496–503.10.1177/1745505716664743Search in Google Scholar
Delbaere A, Smits G, Vassart G, Costagliola S: Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Nat Clin Pract Endocrinol Metab 2006; 2: 590–591.DelbaereASmitsGVassartGCostagliolaS:Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization.Nat Clin Pract Endocrinol Metab2006;2:590–591.10.1038/ncpendmet0319Search in Google Scholar
Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D’Hooghe T, Castilla JA et al.: Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod 2014; 29: 2099–2113.KupkaMSFerrarettiAPde MouzonJErbKD’HoogheTCastillaJA:Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†.Hum Reprod2014;29:2099–2113.10.1093/humrep/deu175Search in Google Scholar
National Institute for Health and Care Excellence: Fertility problems: assessment and treatment. NICE, London: 2013.National Institute for Health and Care Excellence:Fertility problems: assessment and treatment.NICE,London:2013.Search in Google Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group:Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod2004;19:41–47.10.1093/humrep/deh098Search in Google Scholar
Vembu R, Reddy NS: Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in ART. J Hum Reprod Sci 2017; 10: 91–94.VembuRReddyNS:Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in ART.J Hum Reprod Sci2017;10:91–94.10.4103/jhrs.JHRS_15_16Search in Google Scholar
Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I: Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet 2011; 28: 1197–1203.OcalPSahmaySCetinMIrezTGuralpOCepniI:Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.J Assist Reprod Genet2011;28:1197–1203.10.1007/s10815-011-9627-4Search in Google Scholar
Royal College of Obstetricians and Gynaecologists (RCOG): The Management of Ovarian Hyperstimulation Syndrome. Greentop guideline No. 5. RCOG, London 2016. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_5_ohss.pdf.Royal College of Obstetricians and Gynaecologists (RCOG):The Management of Ovarian Hyperstimulation Syndrome.Greentop guideline No. 5. RCOG, London 2016.Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_5_ohss.pdf.Search in Google Scholar
Okohue JE, Onuh SO, Ikimalo JI: Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility. Niger J Clin Pract 2013; 16: 207–210.OkohueJEOnuhSOIkimaloJI:Comparison of IVF/ICSI outcome in patients with polycystic ovarian syndrome or tubal factor infertility.Niger J Clin Pract2013;16:207–210.10.4103/1119-3077.110164Search in Google Scholar
Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome. Lancet 2007; 370: 685–697.NormanRJDewaillyDLegroRSHickeyTE:Polycystic ovary syndrome.Lancet2007;370:685–697.10.1016/S0140-6736(07)61345-2Search in Google Scholar
Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ: AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 2011; 17: 46–54.BroerSLDóllemanMOpmeerBCFauserBCMolBWBroekmansFJ:AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis.Hum Reprod Update2011;17:46–54.10.1093/humupd/dmq03420667894Search in Google Scholar
Sadruddin S, Barnett B, Ku L, Havemann D, Mucowski S, Herrington R et al.: Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment. PLoS One 2020; 15: e0239779.SadruddinSBarnettBKuLHavemannDMucowskiSHerringtonR:Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.PLoS One2020;15:0239779.10.1371/journal.pone.0239779754982233044971Search in Google Scholar
Barbakadze L, Kristesashvili J, Khonelidze N, Tsagareishvili G: The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women. Int J Fertil Steril 2015; 8: 393–398.BarbakadzeLKristesashviliJKhonelidzeNTsagareishviliG:The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.Int J Fertil Steril2015;8:393–398.Search in Google Scholar
Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O et al.: Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet 2013; 30: 657–665.MutluMFErdemMErdemAYildizSMutluIArisoyO:Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.J Assist Reprod Genet2013;30:657–665.10.1007/s10815-013-9975-3366396323508679Search in Google Scholar